UK markets closed
  • FTSE 100

    7,556.23
    -2.26 (-0.03%)
     
  • FTSE 250

    19,363.28
    -46.14 (-0.24%)
     
  • AIM

    853.32
    +2.76 (+0.32%)
     
  • GBP/EUR

    1.1660
    +0.0017 (+0.15%)
     
  • GBP/USD

    1.2296
    +0.0040 (+0.33%)
     
  • BTC-GBP

    13,851.52
    +35.40 (+0.26%)
     
  • CMC Crypto 200

    404.33
    +2.91 (+0.72%)
     
  • S&P 500

    4,071.70
    -4.87 (-0.12%)
     
  • DOW

    34,429.88
    +34.87 (+0.10%)
     
  • CRUDE OIL

    80.34
    -0.88 (-1.08%)
     
  • GOLD FUTURES

    1,797.30
    -3.80 (-0.21%)
     
  • NIKKEI 225

    27,777.90
    -448.18 (-1.59%)
     
  • HANG SENG

    18,675.35
    -61.09 (-0.33%)
     
  • DAX

    14,529.39
    +39.09 (+0.27%)
     
  • CAC 40

    6,742.25
    -11.72 (-0.17%)
     

Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031

ReportLinker
ReportLinker

Summary ASD is one of the most common developmental disorders worldwide. The condition affects 4% of children worldwide, making the disease exceedingly prevalent.

New York, Nov. 03, 2022 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Autism Spectrum Disorder Epidemiology Analysis and Forecast, 2021-2031" - https://www.reportlinker.com/p06360578/?utm_source=GNW

ASD is diagnosed when individuals have difficulty communicating with others, have restricted interests, display repetitive behaviors, and struggle to function in a normal working environment. As symptoms generally manifest in the first two years of life, the condition is regarded as a ‘childhood condition’ however, this report also provides insight into how ASD manifests within the adult population.

Epidemiologists used age- and sex-specific diagnosed and total prevalence rates and diagnosis rates to forecast the total and diagnosed prevalent cases in each of the 7MM using robust market-specific dataEpidemiologists applied the country-specific prevalence rates of ASD to each country’s population to obtain the number of estimated diagnosed and total prevalent cases.

The following data describes epidemiology of ASD cases. In 2021, the 7MM had 4,546,591 diagnosed prevalent cases of ASD which is expected to increase to 4,553,323 cases in 2031, at an annual growth rate (AGR) of 0.01%. In the 7MM, the total prevalent cases of ASD will increase from 7,039,947 cases in 2021, to7,054,851 cases in 2031 at an AGR of 0.02%. This increase is partly attributed to the moderately rising trend in historical prevalence in the 7MM, which can be explained by increased awareness of ASD, and decreased stigma surrounding the condition. The underlying demographic change in the respective markets is also responsible for the increase in prevalence. Increased awareness, and early diagnosis of ASD would facilitate improved access to management strategies and improve the daily lives of people living with ASD.

Scope
- The Autism Spectrum Disorder (ASD) Epidemiology Report provides an overview of the risk factors and global trends of ASD in the seven major markets (7MM: US, France, Germany, Italy, Spain, UK, and Japan).
- This report also includes a 10-year epidemiological forecast for diagnosed and total prevalent cases of ASD segmented by all ages and both sexes. Additionally, diagnosis rates of ASD are included and are segmented into three age groups (children, adolescents, adults).
- The ASD Epidemiology Report is written and developed by Masters- and PhD-level epidemiologists.
- The Epidemiology Report is in-depth, high quality, transparent and market-driven, providing expert analysis of disease trends in the 7MM.

Reasons to Buy
The Autism Spectrum Disorder Epidemiology series will allow you to -
- Develop business strategies by understanding the trends shaping and driving the global ASD market.
- Quantify patient populations in the global ASD market to improve product design, pricing, and launch plans.
- Organize sales and marketing efforts by identifying the demographic with high ASD prevalence that presents the best opportunities ASD therapeutics in each of the markets covered.
- Understand magnitude of ASD by market prevalence.
Read the full report: https://www.reportlinker.com/p06360578/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001